Surveying neurologist perspectives and knowledge of epilepsy surgery to identify barriers to surgery referral (2024)

  • Journal List
  • Epilepsia Open
  • v.9(3); 2024 Jun
  • PMC11145599

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice

Surveying neurologist perspectives and knowledge of epilepsy surgery to identify barriers to surgery referral (1)

Link to Publisher's site

Epilepsia Open. 2024 Jun; 9(3): 960–968.

Published online 2024 Mar 6. doi:10.1002/epi4.12925

PMCID: PMC11145599

PMID: 38446338

Namal U. Seneviratne,Surveying neurologist perspectives and knowledge of epilepsy surgery to identify barriers to surgery referral (2)1 Sophey Y. Ho,2 and Daniel J. Correa3

Author information Article notes Copyright and License information PMC Disclaimer

Associated Data

Supplementary Materials

Abstract

Objective

Epilepsy surgery is an effective means of treating medically refractory epilepsy (MRE), but it remains underused. We aimed to analyze the perspectives and knowledge of referring neurologists in the New York metropolitan area, who serve a large epilepsy population.

Methods

We adapted a previous Canadian survey by Roberts etal. (2015), adding questions regarding demographic descriptors, insurance coverage, training and practice details, and perceived social barriers for patients. We surveyed neurologists directly affiliated with Montefiore Medical Center and those referring to Montefiore's Comprehensive Epilepsy Center. Participants had 10 weeks to fill out an online Qualtrics survey with weekly reminders.

Results

Of 117 neurologists contacted, 51 eligible neurologists completed the survey (63.8% Montefiore, 35.0% referring group). A high proportion of the results were from epilepsy‐trained individuals (41.2%) and neurologists who graduated residency ≤19 years ago (80.4%). 80.4% of respondents felt that epilepsy surgery is safe, but only 56.9% would refer a patient for surgical workup after two failed trials of anti‐seizure medications. Epileptologists and providers with a larger volume of epilepsy patients and electroencephalogram readings had better knowledge of the epilepsy surgery workup guidelines. When asked to rank social barriers to patients receiving surgery, participants were most concerned about lack of social support, financial insecurity, and a patient's dual role as a caregiver.

Significance

Our study suggests continued reluctance of neurologists regarding epilepsy surgery, and deficiencies in the knowledge and adherence to the recommended guidelines. In the context of prior studies, these results showed improved understanding of the definition of MRE (80.4%) and an increased likelihood to refer eligible patients as early as possible (78.4%) in line with current consensus recommendations. The finding that epilepsy‐trained and more epilepsy/electroencephalogram‐facing neurologists showed better understanding of the guidelines suggests that increased education efforts should be targeted at non‐epileptologists.

Plain Language Summary

Our study asked New York City doctors about their approach to epilepsy surgery. Many do not consider it as early as they could in treatment plans. The doctors with extra epilepsy training were better at knowing when to consider surgery.

Keywords: epilepsy surgery, neurologist perspectives, provider education, social determinants, systematic barriers

Key points

  • This is the first survey of neurologist perspectives on epilepsy surgery in the Northeast United States, and the second in the country.

  • Only 56.9% of respondents would refer patients failing two antiseizure medication trials as defined by practice guidelines and consensus recommendations.

  • Epilepsy‐trained individuals and those with higher volumes of epilepsy patients and electroencephalogram reading had greater knowledge about referral guidelines.

  • Participants felt that the greatest social barriers to patients receiving surgery were lack of social support, financial insecurity, and role as a caregiver.

1. INTRODUCTION

Medically refractory epilepsy (MRE) impacts around a third of individuals with epilepsy and is defined as the failure of two adequate trials of antiseizure medication (ASM).1, 2 Epilepsy surgery in appropriately selected patients has been shown to significantly decrease seizure burden with relatively few side effects.3, 4 However, while many people with MRE are eligible for surgical workup, there remains a large gap in epilepsy surgery care with few patients completing their evaluation and receiving surgery.5, 6, 7 Efforts to identify and remove barriers to treatment are targeted at multiple stakeholders along the path to epilepsy surgery, including patient beliefs, systemic healthcare barriers, and referring neurologists.

Previous studies have shown that relatively few neurologists are aware of epilepsy surgery referral guidelines, and many do not adequately refer patients for epilepsy surgery workup.8, 9, 10, 11 Neurologists were shown to overestimate the threshold for referring to epilepsy surgery on multiple fronts, such as seizure frequency and medication failure.8 Some neurologists even perceived epilepsy surgery as dangerous to the patient.9

Social and structural barriers to epilepsy surgery require further elucidation, with one retrospective analysis showing that employed patients were 4.2 times more likely not to proceed with surgery.12 Neurologists provide insight into patient barriers given their close relationships with their patients, with another study showing that neurologists identified inadequate health care resources as the most significant barrier to epilepsy surgery.8

Only one of the previous neurologist surveys studied neurologists in the United States, and no survey has ever been done in the Northeast region of the United States.9 Compared to the rest of the United States, the Northeast region is notable for dense diverse populations and large metropolitan settings.13 New York state specifically has some of the highest numbers of epilepsy cases in the country, making understanding of neurologist perspectives in this region vital.14 Our goal with this survey is to capture the epilepsy surgery perspectives and practices of neurologists within our center or who have referred their patients within the New York metropolitan area. Building on previous work, we adapted the most recent neurologist perspectives survey by Roberts etal.8 and additionally assessed demographic identifiers and United States‐specific barriers.

2. METHODS

2.1. Survey design

We adapted a 2015 survey designed and conducted in Canada by Roberts etal., the most recent of the aforementioned neurologist surveys on epilepsy surgery (Supplement S1).8 In addition to the parameters measured in the original survey, we added several topics specific to the United States patient population, including insurance coverage and potential social barriers. Neurologist‐perceived social barriers were measured through a ranking of the 10 barriers listed in the Montefiore Social Determinants of Health Screener (Supplement S2). We also included demographic information (age, US Census‐based race and ethnicity categories, gender identity), training details, EEG (electroencephalogram) reading volume, epilepsy patient volume, and current epilepsy surgery referral practice.

Subjects who elected not to fill out the survey were diverted to a short form of demographic questions to analyze non‐respondents versus respondents.

A pilot survey was completed by two neurologists outside the NY metropolitan area and referral base to test for any survey difficulties and assess the responses.

2.2. Inclusion/exclusion criteria

Neurologists were offered the survey if they were directly affiliated with the Montefiore health system or at a neurology practice that has previously referred patients to the Montefiore Comprehensive Epilepsy Center for diagnostic testing or further workup. Subjects were excluded if they answered a question stating that they do not treat patients with seizures/epilepsy.

2.3. Reminder schedule

Eligible participants were emailed a Qualtrics survey link. There was a 10‐week collection period, with weekly reminder emails.

2.4. Data analysis

Responses to survey questions were categorized as “No Barrier” and “Barrier” based on whether they were consistent with guidelines. Data analysis was performed by chi‐squared test between respondent characteristics through RStudio (“Spotted Wakerobin” release for Intel Mac OS).

3. RESULTS

One hundred and seventeen neurologists were contacted in the Montefiore network and referring practices. Six total referring practices were contacted for survey participation, of which two did not reply after repeated follow‐up. After establishing approval from the director at the remaining four, surveys were sent to all active neurologists at the practice. After exclusion of neurologists who do not treat patients with epilepsy/seizures, 98 physicians were eligible (58 from Montefiore, 40 from referring groups). Ultimately, 51 eligible physicians completed the survey with a completion rate of 52.0%, with a slightly higher proportion of Montefiore (63.8%) than referring group (35.0%) physicians completing the survey. Demographic data showed primarily White‐identifying individuals (72.5%) filled out the survey, and 41.2% of respondents were Epileptologists (Table1). A majority of participants graduated from residency ≤19 years ago (80.4%). Non‐respondent demographic data could not be evaluated, as the non‐respondents elected to not respond to the optional demographic questions that followed survey refusal.

TABLE 1

Demographic data of 51 respondents within the New York Metropolitan area in a survey of Neurologist's perspectives and understanding of epilepsy surgery guidelines.

Categoryn (%)
Gender
Male29 (56.9)
Female22 (43.1)
Race
White37 (72.5)
Asian10 (19.6)
Black or African American2 (3.9)
Other1 (2.0)
Don't know1 (2.0)
Years since residency graduation
<1024 (47.1)
10–1917 (33.3)
20–296 (11.8)
≥304 (7.8)
Patient age
Adult37 (72.5)
Pediatric3 (5.9)
Both11 (21.6)
Specialty
Epileptologists21 (41.2)
Non‐epileptologists30 (58.8)
Epilepsy patients seen per month
<2030 (58.8)
≥2021 (41.2)
EEGs read per month
None or <528 (54.9)
≥523 (45.1)
Epilepsy surgery referrals in last 5 years
09 (17.6)
1–211 (21.6)
3–1012 (23.5)
11–2011 (21.6)
21–505 (9.8)
>503 (5.9)

Open in a separate window

Proportions of responses associated with no barrier to epilepsy care are shown in Table2. Overall, 80.4% of respondents felt that epilepsy surgery was either very safe or moderately safe, and the same proportion correctly identified that a failure of two ASMs need to be failed before considering epilepsy surgery. Despite this, only 56.9% of respondents said they would refer a patient to epilepsy surgery after the failure of two adequate trials of ASMs. When asked about seizure frequency threshold for epilepsy surgery referral, only 62.7% responded that any frequency is appropriate for referral.

TABLE 2

Survey questions and responses indicating a barrier in a survey of neurologist's perspectives and understanding of epilepsy surgery guidelines (51 respondents within the New York Metropolitan area).

Survey questionResponse(s) indicating no barrierResponse(s) indicating a barrier% “no barrier” response
In your opinion, how safe is epilepsy surgery in carefully selected patients?Very safe, Moderately safeVery dangerous, Moderately dangerous, neither safe nor dangerous80.4
I am quite knowledgeable about the indications for epilepsy surgery.Strongly agree, Somewhat agreeStrongly disagree, somewhat disagree, neither agree or disagree70.6
Are you familiar with the overall content of the American Academy of Neurology clinical practice guidelines on temporal lobe and localized neocortical resections for epilepsy?YesNo60.8
Is there a generally agreed upon definition for drug resistant epilepsy?YesNo, don't know82.4
How many adequately used anti‐seizure medications (ASMs) does a patient with epilepsy need to fail to be considered drug resistant?21 ASM, ≥3 ASM, Fail all, Other80.4
In general, how many ASMs would you try (assuming an adequate trial at an adequate dose) before referring a patient who is still drug resistant for consideration of epilepsy surgery? (text entry)“2”, “two”, “1”, or “one”Any other answer56.9
How long does a patient have to be anti‐seizure medication resistant before you consider referring to be evaluated for epilepsy surgery?As early as possible1 year, 1–2 years, 3–5 years, >5 years, No one78.4
Assuming an adequate trial of anti‐seizure medications, how often do seizures need to happen for a patient with epilepsy to be a surgical candidate? At least…AnyoneYearly, every 6 months, every 3 months, monthly, weekly or more frequent, no one62.7
People without health insurance coverage can be candidates for epilepsy surgeryStrongly agree, somewhat agreeStrongly disagree, somewhat disagree, neither agree or disagree84.3
People with substance abuse disorders can be candidates for epilepsy surgeryStrongly agree, somewhat agreeStrongly disagree, somewhat disagree, neither agree or disagree70.6

Epilepsy surgery should be viewed as a last resort for patients with epilepsy

Strongly disagreeStrongly agree, somewhat agree, neither agree or disagree, somewhat disagree33.3
Patients with focal epilepsy and a normal MRI may benefit from epilepsy surgeryStrongly agree, somewhat agreeStrongly disagree, somewhat disagree, neither agree or disagree92.2
Patients with generalized (non‐focal) epilepsies cannot be candidates for epilepsy surgeryStrongly disagree, somewhat disagreeStrongly agree, somewhat agree, neither agree or disagree66.7
People with developmental delay cannot be candidates for epilepsy surgeryStrongly disagree, somewhat disagreeStrongly agree, somewhat agree, neither agree or disagree94.1
People with psychiatric comorbidities can be candidates for epilepsy surgeryStrongly agree, somewhat agreeStrongly disagree, somewhat disagree, neither agree or disagree88.2
Approximately what percentage of patients experience clinically significant (i.e., disabling) and permanent adverse effects after anterior temporal lobectomy?<5%, 5%–10%10%–50%, >50%94.1
Aside from the very rare occurrence of a surgical death, which one side effect of anterior temporal lobectomy are you most concerned about when counseling your patients about surgical risks (assume a dominant hemisphere resection)?Memory lossAphasia, visual field loss, paralysis, other68.6

Open in a separate window

Responses differentiated by neurologist demographics showed that epileptologists, providers who saw ≥20 epilepsy patients per month, and providers who read ≥5 EEGs per month were more likely than non‐epilepsy specialists to respond that they were more knowledgeable about epilepsy surgery (epileptologist p < 0.001, ≥20 patients p = 0.022, ≥5 EEGs p < 0.001) and that they were familiar with the American Academy of Neurology content guidelines (epileptologist p < 0.001, ≥20 patients p = 0.006, ≥5 EEGs p < 0.001; Figure1). They were also more likely to correctly identify that two trials of adequate ASMs were reason for epilepsy surgery referral (epileptologist p < 0.010, ≥20 patients p = 0.010, ≥5 EEGs p = 0.004). Other neurologist descriptors, including demographic parameters, years since residency, and patient age group, had no effect on epilepsy surgery knowledge and practices.

Open in a separate window

FIGURE 1

Perspectives and knowledge of 51 neurologist referring patients for epilepsy surgery in the New York city region. The y‐axis shows the numbers of participants selecting answers indicative of barriers, categorized by epilepsy training, epilepsy patient load, EEG (electroencephalogram) reading load, and years since residency training. The percent of the subgroup that selected non‐barrier answers is written at the base of each bar. ASM, anti‐seizure medication; MRE, medically refractory epilepsy; Epi, epileptologists; NonEpi, non‐epileptologists; EEG, electroencephalogram.

For the ranking of the importance of social barriers identified on the Montefiore Social Determinants of Health Screener, lack of social support had the highest median rank of 2, with 82.4% of participants ranking it within the top three barriers (Table3). It was followed by financial insecurity (median of 3) and role in caring for others (median of 4).

TABLE 3

Social barriers ranked by participants. Categories developed from social determinants of health screener.

Ranked importance of social barriersMedian rank% in top 3
Lack of social support (family, friends, community programs)282.4
Financial insecurity (difficulty with co‐pays, paid time off)366.7
Role in caring for others (elderly, childcare)439.2
Housing insecurity (unstable or unsafe housing)525.5
Transportation insecurity (inadequate transportation to health needs)523.5
Legal barriers (child/family services, immigration, domestic issues)523.5
Food insecurity (running out of food)69.8
Personal safety barriers (individual hurting or threatening patient)629.4

Open in a separate window

4. DISCUSSION

With improved imaging technology and surgical techniques over the last few decades, epilepsy surgery has proven to be an increasingly effective method of treating MRE that should be considered early in a patient's care.15, 16, 17 Our study showed that neurologists in the New York metropolitan area have a positive perspective of epilepsy surgery but have referral guideline knowledge gaps and practice misalignment that may interfere with prompt surgical referrals and workup. A similar result was seen in a Swedish survey that showed a positive outlook on epilepsy surgery, but only 17.9% of physicians referring appropriately.11 This suggests that faith in the surgery is not an obstacle to care, but further investigation needs to be done into the moderate guideline knowledge and lower practice of guidelines. Although newer neurology residency graduates are expected to learn the guidelines along with their teaching, our study found no significant difference in knowledge based on residency graduation year. However, recent literature shows that neurologists with fewer years of clinical experience were more likely to refer patients to epilepsy surgery,18 suggesting that residency training may not be prioritized as a locus for improved professional development interventions for refractory epilepsy and epilepsy surgery referral education. Future expanded neurologist surveys of neurologist practice perspective should continue assessing for years of experience, as our survey was limited by sample size. The results of our survey indicate that neurologists remain hesitant to refer patients to surgical workup when necessary, as nearly half of the participants would try more than two ASM regimens and would have a certain seizure frequency threshold to begin surgical workup. It should be noted that the survey did not ask the reasoning for a gap between a subject's known guideline understanding and practice of said guideline; therefore, further investigation into this gap is worth further study. Our results are comparable to current observational literature, demonstrating the need for neurologists to feel more comfortable in recommending epilepsy surgery workup when necessary. This study serves as a pilot for this region of the United States, and plans for an expanded multi‐institutional survey are being considered.

There have been several other studies evaluating neurologist perspectives about epilepsy surgery.8, 9, 10, 11 Given that our survey was based off of the Roberts etal. questionnaire, we reviewed their results and population for differences from our findings. It is important to recognize that our study had a higher proportion of epileptologists participating than the Roberts etal.'s (2015) study (41.2% compared to 20.4%) which potentially impacted results. The other three studies did not collect data on the epilepsy specialization of their subjects.9, 10, 11 Regarding the number of ASMs to be considered drug resistant, 80.4% correctly answered two while 51.4% answered correctly in the Roberts etal.'s study, 17.9% answered correctly in the Kumlien etal.'s (2010) study, and 14% in the Hakimi etal.'s (2008) study. To build on these previous studies' findings, we added an open‐ended question asking participants how many ASM trials they would give before considering surgery, and only 56.9% said they would undergo two or fewer trials (Table2). Despite the high percent of respondents correctly identifying the definition of MRE, within our sample we still see hesitance to follow practice guidelines. Another category where responses to our survey showed increasing selection of no‐barrier options was the time with MRE before surgical referral (78.4% vs. 54.1% in Roberts etal. selecting “as early as possible”).8 Conversely, Roberts etal. had a higher proportion of no‐barrier answers regarding epilepsy surgery as a last resort (70.0% vs. 33.3% in our sample). To be more consistent with current consensus among epileptologists, we only allowed “strongly disagree” as a no‐barrier answer given the finality of the “last resort” wording. This limits any comparison with the Roberts etal. question on this concept, as they allowed both the “somewhat” and “strongly disagree” responses as no‐barrier. If the same categorization was used in our study, then 76.5% of participants somewhat or strongly agree, more closely resembling the original study, but in contrast to current recommendation.7 Within our cohort 62.7% of respondents would refer patients regardless of seizure frequency, marginally higher than the 56.6% in Roberts etal. Within the Hakimi etal. cohort, only 10% of respondents did not view seizure frequency as being a criteria for epilepsy surgery referral, with as low as 3% considering surgery in a patient that had seizures once a year. Notably in the Jehi etal.'s consensus recommendations, seizures frequency is not a referral criterion for surgical evaluation.7 Our findings may suggest improvements in understanding of MRE since previous evaluations within the neurology and epilepsy professional communities. This could be the result of improved professional development and trainee education in the last decade.

Our survey assessed several other areas outside the original study, including demographic data, perception of insurance as a barrier, and understanding of surgical side effects. The ranking of the social determinants of health as barriers is unique to our study and provides insight on neurologists' understanding of patient struggles. The Bronx, where many survey participants are employed, has poor health outcomes that are often preventable in nature.19 Additionally, people facing socioeconomic disparities have been shown to have difficulty accessing comprehensive epilepsy care.20 Our study results show that social support and financial security were perceived to be most important in successful surgical workup. This can be implemented into patient care, as unmet social needs identified by hospital screeners can be brought up in conversation by the neurologist and social worker (Supplement S2).

One notable finding is that epileptologists and neurologists with more epilepsy patient care experiences (epilepsy patient volume and EEG reading volume) had significantly better knowledge and understanding of epilepsy surgery referral guidelines than non‐epileptologists. Educational interventions on surgical guidelines have been previously considered, and this finding highlights a specific locus for further education targeted at non‐epileptologists.21 We recommend epilepsy surgery guidelines as topics for grand rounds, and to have lecture series targeted at improving surgical referral guideline adherence and engagement across the broader referral base of each center's encatchment area. Specific education sessions should be considered and developed with the goal of reaching providers outside academic hospitals, as community neurologists may have more difficulty accessing this information and limited interactions with epileptologist colleagues. Additionally, the use of online tools, such as the Canadian Appropriateness of Epilepsy Surgery (CASES) tool, should be encouraged for neurologists who are unsure whether to refer their patient for epilepsy surgery to help reach an evidence‐based decision.22

4.1. Limitations

Our study is potentially limited in its generalizability as the majority of our respondents were directly employed by large academic centers. Compared to the original national survey, it is presumed that our respondents had easier access to academic materials and guidelines. Additionally, all physicians surveyed were either employed by Montefiore or had referred to its Comprehensive Epilepsy Center—therefore, participant access to advanced epilepsy surgery workup may alter their perspectives relative to neurologists without those tools. Sample size is also a limitation, given that only the Montefiore Neurology and regional practice groups referring patients to Montefiore Epilepsy Center sample were contacted of the large New York metropolitan area, and may affect generalizability. Lastly, our study faces nonresponse bias, as neurologists who may have felt uncomfortable with the topic of epilepsy surgery may not have filled out the survey.

5. CONCLUSION

Elucidating and eliminating barriers to epilepsy surgery is a broad task involving perceptive analysis at multiple levels of the surgical workup process. In this study, we looked specifically at the role of the referring neurologist and found many still express hesitance with referring patients to epilepsy surgery. However, our study characterized participants by various demographic and training factors and found that epilepsy‐trained individuals, and individuals who see more epilepsy patients and read more EEGs are more comfortable with the epilepsy surgery process and have a greater understanding of its success and safety. This finding allows educators to focus efforts on those without epilepsy training. As providers continue to streamline and demystify the epilepsy surgery process, it is vital that we continue to educate one another to provide the best possible patient care.

AUTHOR CONTRIBUTIONS

NUS and SYH with DJC in the study design and survey adaptation. NUS and SYH coordinating survey outreach, distribution, and arranged with participants and regional partners the survey scheduling. NUS and SYH contributed to the analysis and drafting of the manuscript. DJC served as the primary mentor and contributed to the writing and editing of the manuscript.

CONFLICT OF INTEREST STATEMENT

D.J.C. has received personal compensation in the range of $0–$499 for serving as a Consultant for Independent Medical Consultants, and personal compensation in the range of $0–$499 for serving as a Consultant for Atheneum Partners, and personal compensation in the range of $10 000–$49 999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology, and research support from Genentech, and research support from Psi Upsilon Foundation Inc., and has stock in Aidin Inc. The remaining authors have no conflicts of interest.

ETHICS STATEMENT

We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Supporting information

Data S1.

Click here to view.(3.4M, docx)

ACKNOWLEDGMENTS

We thank Dr. Sheryl Haut, Dr. Alexis Boro, and Dr. Solomon Moshe (Montefiore Medical Center) for their support on this project, including manuscript review and feedback. This work was supported by the EMPIRE grant (#4630290) and institutional funding from the Einstein Research Fellowship (NUS) and clinical research rotations (SYH).

Notes

Seneviratne NU, Ho SY, Correa DJ. Surveying neurologist perspectives and knowledge of epilepsy surgery to identify barriers to surgery referral. Epilepsia Open. 2024;9:960–968. 10.1002/epi4.12925 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

REFERENCES

1. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, etal. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–1077. 10.1111/j.1528-1167.2009.02397.x [PubMed] [CrossRef] [Google Scholar]

2. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314–319. 10.1056/NEJM200002033420503 [PubMed] [CrossRef] [Google Scholar]

3. Jobst BC, Cascino GD. Resective epilepsy surgery for drug‐resistant focal epilepsy: a review. JAMA. 2015;313(3):285–293. 10.1001/jama.2014.17426 [PubMed] [CrossRef] [Google Scholar]

4. Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, etal. Early surgical therapy for drug‐resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922–930. 10.1001/jama.2012.220 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

5. Jette N, Sander JW, Keezer MR. Surgical treatment for epilepsy: the potential gap between evidence and practice. Lancet Neurol. 2016;15(9):982–994. 10.1016/S1474-4422(16)30127-2 [PubMed] [CrossRef] [Google Scholar]

6. Samanta D, Ostendorf AP, Willis E, Singh R, Gedela S, Arya R, etal. Underutilization of epilepsy surgery: part I: a scoping review of barriers. Epilepsy Behav. 2021;117:107837. 10.1016/j.yebeh.2021.107837 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

7. Jehi L, Jette N, Kwon CS, Josephson CB, Burneo JG, Cendes F, etal. Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League against Epilepsy. Epilepsia. 2022;63(10):2491–2506. 10.1111/epi.17350 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

8. Roberts JI, Hrazdil C, Wiebe S, Sauro K, Vautour M, Wiebe N, etal. Neurologists' knowledge of and attitudes toward epilepsy surgery: a national survey. Neurology. 2015;84(2):159–166. 10.1212/WNL.0000000000001127 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

9. Hakimi AS, Spanaki MV, Schuh LA, Smith BJ, Schultz L. A survey of neurologists' views on epilepsy surgery and medically refractory epilepsy. Epilepsy Behav. 2008;13(1):96–101. 10.1016/j.yebeh.2008.02.003 [PubMed] [CrossRef] [Google Scholar]

10. Erba G, Moja L, Beghi E, Messina P, Pupillo E. Barriers toward epilepsy surgery. A survey among practicing neurologists. Epilepsia. 2012;53(1):35–43. 10.1111/j.1528-1167.2011.03282.x [PubMed] [CrossRef] [Google Scholar]

11. Kumlien E, Mattsson P. Attitudes towards epilepsy surgery: a nationwide survey among Swedish neurologists. Seizure. 2010;19(4):253–255. 10.1016/j.seizure.2010.02.001 [PubMed] [CrossRef] [Google Scholar]

12. Mandge V, Correa DJ, McGinley J, Boro A, Legatt AD, Haut SR. Factors associated with patients not proceeding with proposed resective epilepsy surgery. Seizure. 2021;91:402–408. 10.1016/j.seizure.2021.07.007 [PubMed] [CrossRef] [Google Scholar]

13. Metropolitan and Micropolitan Statistical Areas in the United States and Puerto Rico, United States Census Bureau. Accessed January 23, 2024. https://www2.census.gov/geo/maps/metroarea/us_wall/Dec_2009/cbsa_us_1209_large.gif

14. Epilepsy Data and Statistics. Centers for Disease Control and Prevention. Accessed September 9, 2023. https://www.cdc.gov/epilepsy/data/index.html

15. Berg AT, Langfitt JT, Cascino GD. The changing landscape of epilepsy surgery: no longer the "last resort". Neurology. 2018;91(2):55–56. 10.1212/WNL.0000000000005764 [PubMed] [CrossRef] [Google Scholar]

16. Cross JH. Epilepsy surgery in children–no longer a last resort. Dev Med Child Neurol. 2010;52(2):111–112. 10.1111/j.1469-8749.2009.03599.x [PubMed] [CrossRef] [Google Scholar]

17. Baud MO, Perneger T, Rácz A, Pensel MC, Elger C, Rydenhag B, etal. European trends in epilepsy surgery. Neurology. 2018;91(2):e96–e106. 10.1212/WNL.0000000000005776 [PubMed] [CrossRef] [Google Scholar]

18. Steinbrenner M, Kowski AB, Holtkamp M. Referral to evaluation for epilepsy surgery: reluctance by epileptologists and patients. Epilepsia. 2019;60(2):211–219. 10.1111/epi.14641 [PubMed] [CrossRef] [Google Scholar]

19. Bronx Borough Health Equity Report. 2021. Accessed September 9, 2023. https://www.health.ny.gov/statistics/community/minority/docs/mcd_reports_2021/bronx_county_bronx_borough.pdf

20. Schiltz NK, Koroukian SM, Singer ME, Love TE, Kaiboriboon K. Disparities in access to specialized epilepsy care. Epilepsy Res. 2013;107(1–2):172–180. 10.1016/j.eplepsyres.2013.08.003 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

21. Samanta D, Singh R, Gedela S, Scott Perry M, Arya R. Underutilization of epilepsy surgery: part II: strategies to overcome barriers. Epilepsy Behav. 2021;117:107853. 10.1016/j.yebeh.2021.107853 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

22. Jette N, Quan H, Tellez‐Zenteno JF, Macrodimitris S, Hader WJ, Sherman EMS, etal. Development of an online tool to determine appropriateness for an epilepsy surgery evaluation. Neurology. 2012;79(11):1084–1093. 10.1212/WNL.0b013e3182698c4c [PubMed] [CrossRef] [Google Scholar]

Articles from Epilepsia Open are provided here courtesy of Wiley Periodicals Inc. on behalf of International League Against Epilepsy

Surveying neurologist perspectives and knowledge of epilepsy surgery to identify barriers to surgery referral (2024)
Top Articles
Latest Posts
Article information

Author: Gregorio Kreiger

Last Updated:

Views: 6150

Rating: 4.7 / 5 (77 voted)

Reviews: 84% of readers found this page helpful

Author information

Name: Gregorio Kreiger

Birthday: 1994-12-18

Address: 89212 Tracey Ramp, Sunside, MT 08453-0951

Phone: +9014805370218

Job: Customer Designer

Hobby: Mountain biking, Orienteering, Hiking, Sewing, Backpacking, Mushroom hunting, Backpacking

Introduction: My name is Gregorio Kreiger, I am a tender, brainy, enthusiastic, combative, agreeable, gentle, gentle person who loves writing and wants to share my knowledge and understanding with you.